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Objective: To develop statistical models to predict lung func-
tion and respiratory muscle strength from personal and le-
sion characteristics of individuals with motor complete spi-
nal cord injury. 
Design: Cross-sectional, multi-centre cohort study.
Subjects: A total of 440 individuals with traumatic, motor 
complete spinal cord injury, time post-injury ≥ 6 months, le-
sion level C4–T12, underwent measurements of lung func-
tion and respiratory muscle strength.
Methods: Prediction models for lung volumes and peak inspir-
atory and expiratory muscle strength were calculated. Using 
multi-level regression models, the effects of personal charac-
teristics (gender, age, height, body mass) and lesion character-
istics (time post-injury and lesion level) were determined.
Results: Positive predictors of lung function parameters 
were: male gender, younger age, greater height, greater body 
mass and lower lesion level. For maximal inspiratory mus-
cle strength, male gender, younger age, greater body mass 
and lower lesion level were significant positive predictors, 
whereas for maximal expiratory muscle strength, male gen-
der, younger age, longer time post-injury and lower lesion 
level were positive influencing parameters. 
Conclusion: In contrast to predictive models for able-bodied 
individuals, lung function parameters of persons with spi-
nal cord injury are influenced by body mass and lesion level. 
Maximal expiratory muscle strength improves with longer 
time post-injury.
Key words: regression analysis; reference values; paraplegia; 
respiratory function tests; quadriplegia.
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INTRoduCTIoN
Spinal cord injury (SCI) causes lesion-dependent loss of res-
piratory muscle innervation, which leads to impairments in 
respiratory muscle function and, as a consequence, to reduced 
respiratory muscle strength and lung volume (1). Respiratory 
impairment in persons with SCI may cause various types of 
respiratory complications, such as pneumonia, atelectasis, 
pleural effusions, sleep-disordered breathing or symptoms 
such as dyspnoea (2). Respiratory complications are still the 
major cause of death in persons with SCI (3). Even though 
the occurrence of respiratory complications during the first 2 
years after injury has decreased substantially over the last 30 
years, there has been no improvement thereafter, i.e. in the 
chronic stage of SCI (4).
Causes of respiratory complications are often multi-factorial 
and appear to be associated with low respiratory function (5, 
6) and changes in breathing mechanics (7). With increasing 
time post-injury, the elastic properties of the thorax decrease, 
leading to impairments in lung function and respiratory muscle 
pressure generation capacity (8, 9). Nevertheless, individuals 
with tetraplegia are also able to train their remaining respiratory 
muscles, such as the m. pectoralis (10), which is used to gener-
ate expiratory pressures, or the scalene muscles, which help to 
elevate the ribcage and therefore increase inspiratory capacity 
(11). Thus, even in patients with the same lesion level there 
might be substantial variability in parameters of respiratory 
function. detailed knowledge of additional factors determin-
ing lung function and respiratory muscle strength in persons 
with SCI is therefore needed. There is currently only limited 
knowledge of the parameters influencing lung function and 
respiratory muscle strength, gained from cohort studies of up to 
200 individuals, mainly limited to lung function measurements 
in chronic SCI at around 15–20 years post-injury (12, 13). To 
our knowledge, there are no studies examining the parameters 
influencing respiratory muscle strength in persons with SCI. 
The primary aim of the present study was to close this gap 
by investigating a large sample (n = 440) of individuals with 
motor complete SCI in order to improve our basic knowledge 
of the determinants of lung function and respiratory muscle 
strength in these individuals.
The second aim of this study was to develop an easy to use 
calculator on an open-access web page in order to generate 
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reference values for lung function and respiratory muscle 
strength of individuals with motor complete SCI. The calcula-
tor is based on regression equations from the present study and 
is intended to help clinicians improve their respiratory care 
management of individuals with SCI.
MATERIAl ANd METhodS
Participants
Study participants were recruited from 9 SCI rehabilitation centres: 
8 in the Netherlands and 1 in Switzerland. Inclusion criteria were: 18 
years or older, and a motor complete SCI (American Spinal Injury 
Association Impairment Scale (AIS) A or B) with a lesion level be-
tween C4 and T12 and time post-injury (TPI) ≥ 6 months. Potential 
participants were excluded if they had one or more of the following 
diseases: unstable chronic obstructive pulmonary disease, severe 
atelectasis, lung emphysema with oxygen-dependency or a history of 
pneumothorax. Individuals were also excluded if they had a progressive 
disease or psychiatric diagnosis. level and completeness of injury were 
determined using the AIS (14). All other personal data, such as gender, 
age and height, were recorded by the research assistant before each 
measurement. Body mass was measured on a wheelchair scale, after 
each measurement, once with the individual in the wheelchair and once 
without, in order to calculate the body mass of the individual without 
the wheelchair. Smokers were not excluded from the study in all 9 
centres and smoking data (smoker, ex-smoker, non-smoker, as well as 
pack-years for smokers) was assessed in the dutch centres only.
The local medical ethics committees approved all tests and protocols. 
The tests were conducted by 9 trained paramedic research assistants 
who worked in the participating rehabilitation centres. All research 
assistants received extensive training in how to conduct the tests. 
Personal and lesion characteristics were collected from questionnaire 
data and medical records of the respective clinics. 
Lung function measurements
lung function parameters were measured with the individual in a sit-
ting posture in their own wheelchair using an oxycon delta (oxycon 
delta, Jaeger, hoechberg, Germany) in the dutch centres and a body 
plethysmograph (Master Screen Body, Jaeger, hoechberg, Germany) 
in the Swiss centre. The devices were calibrated before each test. lung 
function measurements were performed according to a standardized 
protocol (15) and consisted of forced vital capacity (FvC), forced 
expiratory volume in 1 s (FEv1) and peak expiratory flow (PEF) 
measurements. Participants breathed through a mouthpiece while 
wearing a nose clip. Each measurement was performed until 3 accept-
able measurements, with 2 measurements within 5%, were registered. 
The higher value of these 2 measurements of each parameter was used 
for further analysis. 
Respiratory muscle strength tests
Peak inspiratory and expiratory muscle strength (Pimax, Pemax) were 
measured using an electronic manometer (Threshold Meter (self-
made), department of Physiology, Radboud university Medical Center, 
Nijmegen, The Netherlands) in the dutch centres and a comparable 
device (MicroRPM, Care Fusion, hoechberg, Germany) in the Swiss 
centre. The manometer was calibrated before each measurement and 
connected to a personal computer for recording the data. Individuals 
were in a sitting position, wearing a nose clip and breathing through a 
mouthpiece with a small leak to prevent glottis closure. Pimax was meas-
ured from the residual volume and Pemax was measured from the total 
lung capacity. Maximum pressures had to be maintained for at least 1 s. 
Individuals repeated each manoeuvre at least 3 times until 2 measure-
ments were recorded within 5%. The highest plateau pressures (1 s) of 
these 2 Pimax and Pemax measurements were used for analysis. 
Statistical analysis
descriptive statistics (median and 2.5–97.5 percentiles) for personal 
and lesion characteristics were calculated for each parameter. values 
were calculated separately for 4 different lesion groups: individuals 
with a high tetraplegia (hT), lesion level C4–C5; individuals with a low 
tetraplegia (lT), lesion level C6–C8; individuals with a high paraplegia 
(hP), lesion level T1–T6; and individuals with a low paraplegia (lP), 
lesion level T7–T12. 
The multi-level modelling program Mlwin (Mlwin, version 1.1; 
Center for Multilevel Modelling, Institute for Education, london, 
uK) (16, 17) was used to determine the relationship of personal 
and lesion characteristics with lung function and respiratory muscle 
strength. outcome variables were FvC, FEv1, PEF, Pimax and Pemax. 
The hierarchy in the data was as follows: individual participants (level 
1) who were grouped in the rehabilitation centres (level 2). In order 
to calculate the influence of the lesion level, 3 dummies were used 
and lT was determined as reference group. Further factors potentially 
influencing lung function and respiratory muscle strength, such as 
gender (male = 1, female = 0), age (years), height (m), body mass 
(kg) and TPI (years), as well as the interaction of lesion level and age 
were added one by one to a basic univariate multilevel regression 
model. Independent variables with p-values < 0.1 were included in a 
subsequent multivariate model. Model fit was assessed with the –2 
log likelihood for the models. A backward selection procedure was 
then carried out, excluding non-significant determinants (p > 0.05) in 
order to create the final multivariate model.
RESulTS
A total of 440 individuals (Table I) were included in the present 
study and completed lung function and respiratory muscle 
strength measurements. 
Lung function
Predicted values of lung function (FvC, FEv1, PEF) for any 
individual with SCI who meets the inclusion criteria of this study 
can be calculated using the regression equations shown in Table 
II. Prediction values of respiratory muscle strength (Pimax and 
Table I. Participants’ characteristics 
Group
Tetraplegia Paraplegia
Totalhigh low high low
Gender, M/F, n 89/17 95/28 90/22 77/22 351/89
TPI, years, median [2.5–97.5%] 8.5 [0.6–33.3] 8.5 [0.8–40.6] 6.6 [0.7–46.1] 6.4 [0.7–44.1] 15.7, 0.7–40.9]
Age, years, median [2.5–97.5%] 43 [21–69] 46 [22–71] 49 [22–73] 45 [21–76] 47, 21–72]
height, cm, median [2.5–97.5%] 178 [158–195] 175 [160–195] 176 [153–192] 176 [156–196] 175, 157–194]
Body mass, kg, median [2.5–97.5%] 73 [44–95] 72 [50–109] 75 [40–106] 74 [50–108] 74, 49–106]
TPI: time post-injury.
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Pemax) can be calculated using the regression equations shown in 
Table III. The calculation of the predicted FvC of, for example, 
a male individual with a T2 lesion, 37 years old, 178 cm tall 
with a body mass of 72 kg would be as follows:
FvC = –1.219 (constant) + 0.371 (HP group) + 0.645 
(male) + (37*–0.026) (age) + (178*0.024) (height) + (72*0.010) 
(body mass) = 3.83 litres.
Group means of FvC, FEv1 and PEF values increased with 
lower lesion level, but showed a large range between individu-
als of the same group (Fig. 1). The 95% confidence intervals 
(95% CI) shown in Table II further support the finding that 
there can be some variability among the predicted values. 
Multivariate analysis showed that all tested lung function pa-
rameters are significantly associated with the level of injury. 
In general, individuals with lower lesion levels showed higher 
values than individuals with higher lesion levels. Men showed 
significantly higher values than women, younger individuals 
showed higher values than older ones, taller and heavier indi-
viduals showed higher values than smaller and lighter ones. 
TPI and the interaction of lesion level and age had no signifi-
cant influence on any of the tested lung function parameters. 
R2 for FvC was 0.55, for FEv1 0.52 and for PEF 0.40, which 
indicates the part of the variance that can be explained by the 
factors included in the model.
Maximal respiratory muscle strength 
Predicted values of respiratory muscle strength (Pimax and Pemax) 
for any individual with SCI who meets the inclusion criteria 
of this study can be calculated using the regression equations 
shown in Table III. Similarly to lung function parameters, the 
group means of Pimax and Pemax increased with lower lesion 
level, but also showed a large range between individuals of 
the same group (Fig. 2), and this is further supported by the 
large CIs shown in Table III. Pimax and Pemax were significantly 
associated with the level of lesion as well as with gender. 
Individuals with lower lesion levels showed higher values 
than those with higher lesion levels, and men showed higher 
Table II. Regression coefficients (βi values) and 95% confidence intervals (CI) from the multivariate multilevel. Regression analysis of lung function 
parameters
FvC (l)
β [95% CI]
FEv1 (l)
β [95% CI]
PEF (l/s)
β [95% CI]
Constant –1.219 [0.569 to –3.007] –0.798 [0.692 to –2.288] –1.327 [2.025 to –4.679]
ΔHT–LT –0.599* [–0.387 to –0.811] –0.531* [–0.357 to –0.705] –1.105* [–0.733 to –1.477]
ΔLT–HP 0.371* [0.583 to 0.159] 0.280* [0.458 to 0.102] 0.902* [1.316 to 0.488]
ΔLT–LP 0.791* [1.013 to 0.570] 0.608* [0.794 to 0.422] 1.725* [2.203 to 1.247]
Gender 0.645* [0.868 to 0.422] 0.505* [0.691 to 0.318] 1.049* [1.467 to 0.632]
Age (years) –0.026* [–0.020 to –0.032] –0.025* [–0.021 to –0.029] –0.031* [–0.021 to –0.041]
height (cm) 0.024* [0.034 to 0.014] 0.021* [0.029 to 0.013] 0.032* [0.052 to 0.012]
Body mass (kg) 0.010* [0.016 to 0.004] 0.006* [0.010 to 0.002] 0.015* [0.025 to 0.005]
TPI (years) n.s. n.s. n.s.
*Significant influencing factor (p < 0.05); n.s.: not significant.
FvC: forced vital capacity; FEv1: forced expiratory volume in 1 s; PEF: peak expiratory flow; β: regression coefficient for each independent variable; 
CI: confidence interval; HT: high tetraplegia; LT: low tetraplegia; HP: high paraplegia; LP: low paraplegia; ΔHT–LT/ΔLT–HP/ΔLT–LP: group dummies 
with lT as reference; gender: 0: women; 1: men; TPI: time post-injury.
Table III. Regression coefficients (βi values) and 95% confidence intervals 
(CI) from the multivariate multilevel regression analysis of respiratory 
muscle strength parameters
Pimax (cmh2o)
β [95% CI]
Pemax (cmh2o)
β [95% CI]
Constant 45.31 [62.48; 28.14] 55.72 [68.70; 42.75]
ΔHT–LT –11.98* [–4.38; –19.59] –7.87 [1.71; –17.45]
ΔLT–HP 10.90 [19.52; 2.28] 9.09 [17.77; 0.41]
ΔLT–LP 19.89* [30.96; 8.82] 36.18* [48.70; 23.66]
Gender 14.95* [22.87; 7.03] 19.74* [28.11; 11.37]
Age (years) –0.60* [–0.38; –0.82] –0.52* [–0.17; –0.87]
height (cm) n.s. n.s.
Body mass (kg) 0.51* [0.73; 0.29] n.s.
TPI (years) n.s. 0.46* [0.75; 0.17]
*Significant influencing factor (p < 0.05); n.s.: not significant. 
Pimax: maximal inspiratory pressure; Pemax: maximal expiratory pressure; 
β: regression coefficient for each independent variable; CI: confidence 
interval; hT: high tetraplegia;  lT: low tetraplegia; hP: high paraplegia; 
LP: low paraplegia; ΔHT–LT/ΔLT–HP/ΔLT–LP: group dummies with LT 
as reference; gender: 0: women; 1: men; TPI: time post-injury.
Fig. 1. Boxplots for forced vital capacity (FvC), forced expiratory volume 
in 1 s (FEv1) and peak expiratory flow (PEF) given for the 4 lesion-level 
subgroups. hT: individuals with high tetraplegia (C4, C5); lT: individuals 
with low tetraplegia (C6–C8); hP: individuals with high paraplegia 
(T1–T6); lP: individuals with low paraplegia (T7–T12); °: outlier.
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values than women. Increasing age had a negative influence 
on Pimax and Pemax, whereas greater body mass was positively 
associated with Pimax but not with Pemax. height and TPI had 
no significant influence on Pimax. Pemax was positively associ-
ated with TPI. The interaction of lesion level and age had no 
significant influence on Pimax and Pemax and therefore was not 
included in the final models. The total variance of the models 
that can be explained by included factors (R2), was 0.37 for 
Pimax and 0.46 for Pemax.
dISCuSSIoN
Summary of the main findings
lung function and respiratory muscle strength of persons with 
SCI are influenced by similar parameters as in able-bodied 
persons (15, 18), such as gender, age and height, but addi-
tionally by body mass and lesion level. Interestingly, Pemax is 
the only parameter that is influenced by TPI. In addition, the 
open-access webpage (www.scionn.nl/RefCalc.xls) has been 
created in order to make it easy to calculate reference values 
for individuals with motor complete SCI. The system auto-
matically calculates the predicted lung function or respiratory 
strength value from the personal and lesion characteristics of 
the individual. Furthermore, if measured values of the actual 
individual are entered, the percentage of the predicted value 
for this particular individual will be calculated. Instructions 
on how to use the tool are included on the website. 
Lung function
The regression coefficients of the parameter “age” in the 
present study are all between –0.025 and –0.031 (Table II), 
representing a decrease in lung function of between 25 and 
31 ml or ml/s for each year. Interestingly, these coefficients 
for persons with motor complete SCI are in accordance with 
those for able-bodied persons, who lose between 26 and 43 ml 
or ml/s for each year (19). There was no additional decrease 
in lung function with increasing TPI. 
Coughing ability is an important function for prevention 
of respiratory complications, especially pneumonia. It has 
been shown that FEv1 does not correlate with the clearance 
efficacy of coughing (20). PEF may be more closely associ-
ated with coughing than FvC and FEv1. In order to produce 
an effective cough, a PEF of 5–6 l/s is necessary (21). The 
mean PEF of persons with tetraplegia in the present study 
was approximately 4–5 l/s, indicating that these persons are 
not able to produce an effective cough and therefore may be at 
higher risk for respiratory complications. Thus, PEF could be 
a useful screening parameter in persons with SCI, in order to 
detect risk factors for respiratory complications early on. The 
fact that body mass positively influences lung function seems 
confusing, since it is known that being overweight decreases 
lung function in the able-bodied population (22). Neverthe-
less, our sample of individuals was not overweight (Table I), 
having a mean body mass index (BMI) of 23.9 kg/m2. Jones 
et al. (23) showed that vital capacity is negatively influenced 
mainly in persons with a BMI of > 30 kg/m2. 
Respiratory muscle strength
Similar to regression equations for lung function, a lower le-
sion level had significant positive effects on Pimax and Pemax. 
Similar to in able-bodied individuals and the models for 
lung function, gender showed significant effects on Pemax and 
Pimax, with higher estimates for men than women. Similarly to 
reference equations for able-bodied persons (18), increasing 
age had a significant negative effect on respiratory muscle 
strength in persons with SCI. Interestingly, Pemax was posi-
tively associated with TPI. This is an unexpected result that 
may have been influenced by selection bias. In an earlier study 
we showed that Pemax increases in individuals with tetraplegia 
at least until 2 years post-injury (24). however, the increase 
in Pemax with increasing TPI in the present study may result 
from selection of individuals with good respiratory function, 
i.e. those who survived. 
Clinical relevance
This is the first study investigating parameters influencing 
lung function and respiratory muscle strength in a large cohort 
of motor complete individuals with SCI. our data showed 
that, compared with able-bodied persons, other parameters 
such as lesion level and body mass are important parameters 
influencing respiratory function in individuals with SCI. De-
tailed knowledge of these parameters may help to optimize 
respiratory care management in daily clinical practice in the 
future because respiratory complications in individuals with 
tetraplegia are common and are still the major cause of death 
(3). First studies show that respiratory muscle training may 
improve respiratory function (25–27), but further studies with 
Fig. 2. Boxplots for maximal inspiratory pressure (Pimax) and maximal 
expiratory pressure (Pemax) given for the 4 lesion-level subgroups. hT: 
individuals with high tetraplegia (C4, C5); lT: individuals with low 
tetraplegia (C6–C8); hP: individuals with high paraplegia (T1–T6); lP: 
individuals with low paraplegia (T7–T12); °: outlier.
Pr
es
su
re
 [c
m
H
2O
] 
Pimax 
Pemax 
J Rehabil Med 44
646 G. Mueller et al.
larger sample sizes and of high methodological quality are 
necessary (28, 29).
Furthermore, the easy to use open-access tool supports phy-
sicians in estimating individual predicted lung function and 
respiratory muscle strength values from personal and lesion-
level data. Since innervation of respiratory muscles is highly 
influenced by the lesion level, this has to be considered for 
calculating reference values of lung function for persons with 
SCI. The results provided by our newly designed reference 
values calculator give a rapid general overview of the current 
lung function status of an individual with SCI and should 
therefore improve the individual and long-term respiratory 
care of persons with SCI.
Study limitations 
Respiratory complications occur frequently in persons with SCI 
(30, 31) and seem to be associated with low respiratory function 
(5, 6). This study provides further knowledge of respiratory 
function in persons with SCI. however, it cannot provide any 
information about risk of respiratory complications result-
ing from a decrease in respiratory function. To evaluate this 
important question, longitudinal studies assessing respiratory 
function and complication rates are needed. 
Smoking may be an additional influencing parameter on 
lung function values. Since we only had smoking data from 
the 8 dutch centres, we could not include this parameter in 
our models. however, we analysed the dutch sub-set of data 
to test any influence of smoking on the measured parameters 
of respiratory function. Interestingly we found no significant 
effect of smoking or the number of pack-years on any of the 
tested parameters.
Examining the R2 values for the 5 models assessed indicates 
that only 37–55% of the variability in respiratory function values 
can be explained by the parameters included in our models. The 
large CIs shown in Tables II and III further show that there may 
be some variability in the predicted values, which should be 
taken into account when interpreting calculated and measured 
values. This makes clear that other factors, such as physical fit-
ness, respiratory muscle training, medication or smoking, may 
further influence respiratory function parameters. Nevertheless, 
we believe that it is at least a clinically relevant starting point 
to be able to explain 37–55% of the variability. Including these 
proportions in interpretation of the data shows that it is worth 
measuring lung function and respiratory muscle strength, but 
assessing additional potentially influencing factors that are not 
included in our models (see above) may help the clinician to 
explain why a patient is above or below the reference value and 
may improve individuals’ respiratory care. 
A further limitation of this study is the lack of validation of 
our models. We tested our models with a dozen individuals, 
and the values were quite accurate. however, a new study with 
prognostic models, including more potentially influencing 
factors, is necessary for a proper validation of these models. 
We plan to test another 400–500 individuals in a subsequent 
multi-centre cohort study in order to validate the models pre-
sented in this paper.
Conclusion
Lesion level has a significant influence on lung function and 
respiratory muscle strength in persons with SCI. lesion level 
should therefore be considered carefully when assessing res-
piratory function in persons with SCI. using the regression 
equations presented in this study may be helpful for calculat-
ing “reference-like” data to compare lung function of persons 
with SCI. Persons with motor complete tetraplegia should 
be screened regularly by testing lung function and respira-
tory muscle strength with the aim of preventing respiratory 
complications. 
ACKNoWlEdGEMENTS
The dutch part of this study was supported by the dutch health Research 
and development Council, ZoN-MW Rehabilitation programme, grant 
number 1435.0003.
The contribution of the 9 participating rehabilitation centres, in particu-
lar that of the research assistants collecting all the data, is highly appreci-
ated: Sacha van langeveld (de hoogstraat, utrecht), Annelieke Niezen/ 
Peter luthart (Rehabilitation Center Amsterdam), Marijke Schuitemaker 
(het Roessingh, Enschede), Karin Postma (Rijndam Revalidatiecentrum, 
Rotterdam), Jos Bloemen (hoensbroeck Revalidatiecentrum, hoensbr-
oeck), hennie Rijken (Sint Maartenskliniek, Nijmegen), Ferry Woldring 
(Beatrixoord, haren), linda valent (heliomare, Wijk aan Zee) and Claudia 
Muri (Swiss Paraplegic Center, Nottwil). We thank Jörg Krebs for criti-
cally reading the manuscript.
REFERENCES
Sipski Ml, Richards JS. Spinal cord injury rehabilitation: state of 1. 
the science. Am J Phys Med Rehabil 2006; 85: 310–342.
Brown R, diMarco AF, hoit Jd, Garshick E. Respiratory dysfunc-2. 
tion and management in spinal cord injury. Respir Care 2006; 
51: 853–868.
van den Berg ME, Castellote JM, de Pedro-Cuesta J, Mahillo-3. 
Fernandez I. Survival after spinal cord injury: a systematic review. 
J Neurotrauma 2010; 27: 1517–1528.
Strauss dJ, devivo MJ, Paculdo dR, Shavelle RM. Trends in life 4. 
expectancy after spinal cord injury. Arch Phys Med Rehabil 2006; 
87: 1079–1085.
Winslow C, Rozovsky J. Effect of spinal cord injury on the respira-5. 
tory system. Am J Phys Med Rehabil 2003; 82: 803–814.
Fishburn MJ, Marino RJ, ditunno JF Jr. Atelectasis and pneu-6. 
monia in acute spinal cord injury. Am J Phys Med Rehabil 1990; 
71: 197–200.
de Troyer A, Estenne M, heilporn A. Mechanism of active expira-7. 
tion in tetraplegic subjects. N Engl J Med 1986; 314: 740–744.
Goldman JM, Williams SJ, denison dM. The rib cage and abdomi-8. 
nal components of respiratory system compliance in tetraplegic 
patients. Eur Respir J 1988; 1: 242–247.
de Troyer A, heilporn A. Respiratory mechanics in quadriplegia. 9. 
The respiratory function of the intercostal muscles. Am Rev Respir 
disease 1980; 122: 591–600.
Estenne M, Knoop C, vanvaerenbergh J, heilporn A, de Troyer 10. 
A. The effect of pectoralis muscle training in tetraplegic subjects. 
Am Rev Respir disease 1989; 139: 1218–1222.
de Troyer A, Estenne M, vincken W. Rib cage motion and mus-11. 
cle use in high tetraplegics. Am Rev Respir disease 1986; 133: 
1115–1119.
Almenoff Pl, Spungen AM, lesser M, Baumann WA. Pulmonary 12. 
function survey in spinal cord injury: influences of smoking and 
level and completeness of injury. lung 1995; 173: 297–306.
J Rehabil Med 44
647Prediction models for lung function after SCI
linn WS, Adkins Rh, Gong h Jr, Waters Rl. Pulmonary func-13. 
tion in chronic spinal cord injury: a cross-sectional survey of 222 
southern California adult outpatients. Arch Phys Med Rehabil 
2000; 81: 757–763.
American Spinal Injury Association (ASIA). International Stand-14. 
ards for Neurological Classification of SCI. Chicago: American 
Spinal Injury Association; 2000.
American Thoracic Society. Standardization of spirometry, 1994 15. 
update. Am J Respir Crit Care Med 1995; 152: 1107–1136.
Twisk JW. Applied longitudinal data analysis for epidemiology, a 16. 
practical guide. Amsterdam: Cambridge university Press; 2003.
Rasbash J, Browne W, Goldstein h, yang M, Plewis I, healy M, et 17. 
al. A user’s guide to Mlwin. london: Centre for Multilevel Model-
ling, Institute of Education, university of london; 2000.
Black lF, hyatt RE. Maximal respiratory pressures: normal values 18. 
and relationship to age and sex. Am Rev Respir disease 1969; 
99: 696–702.
Quanjer Ph, Tammeling GJ, Cotes JE, Pedersen oF, Peslin R, 19. 
Yernault JC. Lung volumes and forced ventilatory flows. Report 
Working Party Standardization of lung Function Tests, European 
Community for Steel and Coal. Official Statement of the European 
Respiratory Society. Eur Respir J Suppl 1993; 16: 5–40.
hasani A, Pavia d, Agnew JE, Clarke SW. Regional lung clearance 20. 
during cough and forced expiration technique (FET): effects of 
flow and viscoelasticity. Thorax 1994; 49: 557–561.
Fugl-Meyer AR. The respiratory system. In: vinken PJ, Bruyn 21. 
GW, editors. handbook of clinical neurology. New york: American 
Elsevier; 1976, p. 335–349.
Chen y, horne Sl, dosman JA. Body weight and weight gain 22. 
related to pulmonary function decline in adults: a six year follow 
up study. Thorax 1993; 48: 375–380.
Jones Rl, Nzekwu MM. The effects of body mass index on lung 23. 
volumes. Chest 2006; 130: 827–833.
Mueller G, de Groot S, van der Woude l, hopman MT. Time-24. 
courses of lung function and respiratory muscle pressure generat-
ing capacity after spinal cord injury: a prospective cohort study. 
J Rehabil Med 2008; 40: 269–276.
liaw My, lin MC, Cheng PT, Wong MK, Tang FT. Resistive inspira-25. 
tory muscle training: its effectiveness in patients with acute complete 
cervical cord injury. Arch Phys Med Rehabil 2000; 81: 752–756.
Rutchik A, Weissman AR, Almenoff Pl, Spungen AM, Bauman 26. 
WA, Grimm dR. Resistive inspiratory muscle training in subjects 
with chronic cervical spinal cord injury. Arch Phys Med Rehabil 
1998; 79: 293–297.
van houtte S, vanlandewijck y, Kiekens C, Spengler CM, Gosse-27. 
link R. Patients with acute spinal cord injury benefit from normo-
capnic hyperpnoea training. J Rehabil Med 2008; 40: 119–125.
Sheel AW, Reid Wd, Townson AF, Ayas NT, Konnyu KJ. Effects 28. 
of exercise training and inspiratory muscle training in spinal 
cord injury: a systematic review. J Spinal Cord Med 2008; 31: 
500–508.
van houtte S, vanlandewijck y, Gosselink R. Respiratory muscle 29. 
training in persons with spinal cord injury: a systematic review. 
Resp Med 2006; 100: 1886–1895.
DeVivo MJ, Black KJ, Stover SL. Causes of death during the first 30. 
12 years after spinal cord injury. Arch Phys Med Rehabil 1993; 
74: 248–254.
Alander dh, Andreychik dA, Stauffer ES. Early outcome in cervi-31. 
cal spinal cord injured patients older than 50 years of age. Spine 
1994; 19: 2299–2301.
J Rehabil Med 44
